head-and-neck-neoplasms

Documents about head-and-neck-neoplasms

• A Study in Advanced Solid Tumors#825908ClinicalTrials.gov
• Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer#897531ClinicalTrials.gov
• Docetaxel in Head and Neck Cancer#904670ClinicalTrials.gov
• Tranexamic Acid and Head and Neck Surgery Patients#906747ClinicalTrials.gov
• Head and Neck Cancer Study Project in the Geriatric Population#272349ClinicalTrials.gov
• Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer#849998ClinicalTrials.gov
• Exercise After Radiation for Head & Neck Cancer#833645ClinicalTrials.gov
• Photobiomodulation Therapy in Patients With Head and Neck Cancer Post-Radiotherapy#840456ClinicalTrials.gov
• A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer#160362ClinicalTrials.gov
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery#833609ClinicalTrials.gov
• Pilot Study for Locally Advanced Head and Neck Cancer#870408ClinicalTrials.gov
• Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma#870888ClinicalTrials.gov
• A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC#885522ClinicalTrials.gov
• BIBW 2992 (Afatinib) in Head & Neck Cancer#876595ClinicalTrials.gov
• Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck#429741ClinicalTrials.gov
• Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study)#850320ClinicalTrials.gov
• Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma#387157ClinicalTrials.gov
• Heavy Strength Training in Head and Neck Cancer Survivors#903773ClinicalTrials.gov
• Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer#832208ClinicalTrials.gov
• Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer#833567ClinicalTrials.gov
• Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer#867288ClinicalTrials.gov
• Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients#887213ClinicalTrials.gov
• Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma#208444ClinicalTrials.gov
• Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer#256834ClinicalTrials.gov
• Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck#981938ClinicalTrials.gov
• Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery#829300ClinicalTrials.gov
• Application of artificial intelligence in head and neck squamous cell carcinoma.#9724PubMed
• Phase II Trial of Allovectin-7® for Head and Neck Cancer#857005ClinicalTrials.gov
• Robot Assisted Supraomohyoid Neck Dissection Via Retroauricular Approach#877484ClinicalTrials.gov
• Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial#826466ClinicalTrials.gov
• Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer#895701ClinicalTrials.gov
• Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck#121357ClinicalTrials.gov
• Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer#891093ClinicalTrials.gov
• Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer#911413ClinicalTrials.gov
• Cox-2 Inhibition in Radiation-induced Oral Mucositis#896780ClinicalTrials.gov
• Impact of Fixed Dentures in Head and Neck Cancer (IMFDHAC)#810843ClinicalTrials.gov
• Effects of a Home-Based Exercise Program During Radiotherapy#886159ClinicalTrials.gov
• The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients#904795ClinicalTrials.gov
• Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck#912150ClinicalTrials.gov
• The Translational Research Image-Guided Operating Room (TRIGORA): Intraoperative 3D Imaging for Head & Neck Surgical Patients#914289ClinicalTrials.gov
• HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer#279527ClinicalTrials.gov
• Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery?#906835ClinicalTrials.gov
• Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients#907335ClinicalTrials.gov
• Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma#910218ClinicalTrials.gov
• Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms#835852ClinicalTrials.gov
• Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive#800378ClinicalTrials.gov
• H&N Cancer; Survivorship and Late Effects#881091ClinicalTrials.gov
• Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)#982720ClinicalTrials.gov
• Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck#842170ClinicalTrials.gov
• Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck#838378ClinicalTrials.gov